Oxaliplatin treatment had a striking antitumor effect on p53+/+HCT116 tumor xenografts (Fig. 5A), whereas the growth of p53−/−HCT116 xenografts was not significantly affected by oxaliplatin treatment (Fig. 5B). This evidence concerns the gene TP53 and neoplasm.